PT Jayamas Medica Industri Tbk
Bear Case (25th pct.)
-14.1% vs price
Base Case (Median)
-4.7% vs price
Bull Case (75th pct.)
32.2% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $194.49 | -4.7% | High (40%) |
| PE Comparable | $321.83 | 57.8% | Medium (25%) |
| Growth Trajectory DCF | $270.70 | 32.7% | Medium (20%) |
| Graham Number | $181.29 | -11.1% | Medium (40%) |
| EV/EBITDA | $169.14 | -17.1% | Medium (20%) |
| EV/FCF | $160.88 | -21.1% | Medium (20%) |
| Earnings Power Value | $268.65 | 31.7% | Medium (50%) |
Based on 7 out of 8 methods, OMED.JK appears fairly valued at the current price of $204.00. The base case fair value of $194.49 implies 4.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.